Back to results
US 11,111,273 B2Granted
Cyclic peptides multimers targeting alpha-4-beta-7 integrin
AssigneeZealand Pharma A/S
InventorsMohammed Monzur Morshed, Sai Kumar Chakka, Jennifer L. Hickey, Manuel Perez Vazquez, Andrew Roughton, Adam Paul Kafal, Narendrakumar B. Patel
Life of this patent
Estimating the term…
Abstract
There is described herein, multimers comprising a plurality of compounds covalently linked together, the compounds independently being of formula (I).
Claims3
A homodimer of two moieties covalently linked together by an amide bond to a diphenic acid residue, the moieties both being of formula (I):
- wherein
- R1 is H;
- R2 is H;
- R3 is CH3;
- R4 is H;
- R5 is an amide of the formula —C(O)NR**R***, wherein R** is H and R*** is tert-butyl;
- R6 along with R7 together form the pyrrolidine ring of Pro;
- R8 is H;
- n is 1;
- wherein Z is an amino terminus of an amino acid;
- —C═O— adjacent L is the carboxy terminus of an amino acid;
- and L along with Z and —C═O— is a peptide having the following formula:
- Xy—Xz—X1—X2—X3
- wherein
- Xy is 3-aminomethyl-4-[4-(1-piperazinyl)-phenyl]-benzoic acid, in which the piperazinyl amine nitrogen at the 4-position of the piperazinyl ring is covalently bound via the amide bond to the diphenic acid residue to form the homodimer;
- Xz is absent;
- X1 is Leucine;
- X2 is Asp;
- and
- X3 is Thr;
- or a pharmaceutically acceptable salt thereof.
18 more elements
Dependencies are inferred from the claim text.